Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | Yes |
Is asset turnover increasing? | Yes | No |
Is equity multiplier increasing? | Yes | No |
Competitors Used |
---|
JW Shinyak Corporation |
Kyung Nam Pharm Co.,Ltd. |
Enzychem Lifesciences Corporation |
WITHUS PHARMACEUTICAL Co.,LTD. |
Korean Drug Co., Ltd. |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
A067290 | A053950 | A183490 | A330350 | A014570 | A012790 | |||
Return On Equity | ||||||||
Latest Twelve Months | 45% | -3% | -12% | 5% | 1% | 9% | ||
Fiscal Year - 1 | -103% | -10% | -5% | 9% | -6% | 11% | ||
Fiscal Year - 2 | 3% | -9% | -18% | 3% | 15% | 10% | ||
Fiscal Year - 3 | 2% | -5% | -37% | 5% | 12% | 6% | ||
Fiscal Year - 4 | -11% | -9% | -24% | 10% | 11% | 7% | ||
Fiscal Year - 5 | 3% | -10% | -25% | 18% | 6% | 7% | ||
Average | -10% | -8% | -20% | 8% | 6% | 8% | ||
Median | 2% | -9% | -21% | 7% | 8% | 8% | ||
Benchmarks | Ticker | |||||||
JW Shinyak Corporation | KOSDAQ:A067290 | |||||||
Kyung Nam Pharm Co.,Ltd. | KOSDAQ:A053950 | |||||||
Enzychem Lifesciences Corporation | KOSDAQ:A183490 | |||||||
WITHUS PHARMACEUTICAL Co.,LTD. | KOSDAQ:A330350 | |||||||
Korean Drug Co., Ltd. | KOSDAQ:A014570 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | A067290 | A053950 | A183490 | A330350 | A014570 | A012790 | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Mar-25 | Mar-25 | Dec-24 | Mar-25 | Mar-25 | Mar-25 | ||
Revenues | ||||||||
Latest Twelve Months | 88,880 | 56,184 | 77,378 | 102,506 | 66,774 | 85,921 | ||
Fiscal Year | 93,014 | 60,792 | 77,378 | 102,722 | 73,001 | 89,440 | ||
Fiscal Year - 1 | 104,235 | 59,303 | 76,039 | 80,119 | 81,375 | 89,135 | ||
Fiscal Year - 2 | 102,710 | 59,000 | 26,638 | 64,680 | 79,984 | 80,007 | ||
Fiscal Year - 3 | 100,966 | 64,623 | 22,975 | 57,419 | 74,466 | 61,754 | ||
Fiscal Year - 4 | 103,803 | 70,933 | 25,818 | 53,406 | 66,789 | 61,438 | ||
Fiscal Year - 5 | 102,531 | 44,806 | 31,469 | 51,732 | 55,529 | 60,648 | ||
Net Income | ||||||||
Latest Twelve Months | 11,941 | (3,116) | (22,107) | 4,412 | 447 | 12,654 | ||
Fiscal Year | 5,082 | (2,648) | (22,107) | 4,785 | 2,995 | 14,301 | ||
Fiscal Year - 1 | (37,357) | (8,339) | (9,326) | 7,959 | (4,917) | 13,641 | ||
Fiscal Year - 2 | 1,400 | (7,828) | (24,934) | 2,479 | 11,809 | 12,157 | ||
Fiscal Year - 3 | 884 | (3,209) | (26,923) | 4,264 | 9,042 | 6,679 | ||
Fiscal Year - 4 | (6,446) | (5,135) | (17,443) | 6,652 | 7,360 | 7,544 | ||
Fiscal Year - 5 | 1,442 | (4,546) | (16,444) | 8,661 | 3,895 | 7,257 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 66,268 | 159,606 | 211,546 | 131,821 | 96,747 | 157,426 | ||
Latest Fiscal Quarter | 61,153 | 160,219 | 181,744 | 132,098 | 90,894 | 166,851 | ||
Fiscal Year | 63,035 | 166,584 | 181,744 | 134,687 | 88,887 | 165,861 | ||
Fiscal Year - 1 | 65,619 | 166,609 | 211,546 | 130,780 | 89,709 | 152,460 | ||
Fiscal Year - 2 | 94,094 | 138,269 | 247,555 | 119,395 | 94,516 | 142,832 | ||
Fiscal Year - 3 | 92,004 | 125,307 | 133,084 | 118,979 | 88,613 | 128,974 | ||
Fiscal Year - 4 | 96,327 | 126,655 | 123,802 | 106,180 | 83,345 | 124,810 | ||
Fiscal Year - 5 | 136,855 | 74,460 | 84,991 | 76,283 | 75,850 | 117,838 | ||
Fiscal Year - 6 | 109,206 | 53,157 | 67,045 | 69,018 | 72,962 | 106,404 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 18,017 | 77,743 | 193,516 | 90,985 | 78,802 | 136,592 | ||
Latest Fiscal Quarter | 34,922 | 113,490 | 160,353 | 94,768 | 77,162 | 146,325 | ||
Fiscal Year | 26,900 | 115,223 | 160,353 | 93,117 | 78,106 | 146,506 | ||
Fiscal Year - 1 | 16,770 | 79,362 | 193,516 | 90,278 | 77,090 | 134,895 | ||
Fiscal Year - 2 | 55,973 | 93,771 | 201,474 | 83,036 | 84,713 | 123,277 | ||
Fiscal Year - 3 | 55,444 | 72,529 | 74,472 | 80,905 | 76,690 | 113,196 | ||
Fiscal Year - 4 | 56,556 | 57,364 | 72,458 | 76,877 | 70,871 | 107,484 | ||
Fiscal Year - 5 | 66,144 | 61,194 | 73,873 | 52,429 | 65,050 | 101,245 | ||
Fiscal Year - 6 | 33,489 | 28,912 | 58,817 | 44,096 | 62,799 | 95,185 |